Dr. Kim of the Korean Precision Medicines Enterprice is confirmed as speaker at the International Conference on Perspectives in Precision Medicine

02-01-2018

Dr. Yeul Hong Kim, Professor at Korea University College of Medicine & Director of the Korean Precision Medicine Enterprise will present the initiative in Copenhagen 28 February - 1 March 2018

Dr. Kim of the Korean Precision Medicines Enterprice is confirmed as speaker at the International Conference on Perspectives in Precision Medicine

The International Conference on Perspectives in Precision Medicine, 28 February - 1 March 2018, in Copenhagen, is honored to announce that Dr. Yeul Hong Kim will present the Korean goverment project on Precision Medicine.

The project was launched in 2017 and composed of the Cancer Diagnosis & Treatment Enterprise (K-MASTER) and the Precision-Hospital Information System Enterprise (P-HIS).

The research objective of the K-MASTER is developing a global precision medical cancer diagnosis and treatment method by establishing a comprehensive integration platform with the best possible integration of the molecular diagnosis and new targeted agents, which can be used in the near term. Also, the K-MASTER aims to operate and expand the development of a large scale genomic and clinical data warehouse, combined with various solution developments for precision medicine of cancer patients.

The research objective of the P-HIS is developing Internet of Things, Cloud Computing, Big Data, and Mobile-Based Precision Healthcare Hospital Information System to integrate and analyze diverse medical data and use in real-time care. At a 2nd stage, the Korean government and the P-HIS Enterprise will promote the spread and export of cloud-based precision medical hospital information systems in Korea and into overseas export businesses.

Yeul Hong Kim, MD, PhD, is Professor of Medical Oncology at the Korea University College of Medicine and Director of the Korea University Cancer Institute. He is certified in internal medicine and medical oncology by the Korean Association of Internal Medicine. And he is a pioneer in Korea in the area of liquid biopsy using circulating tumor DNA isolated from cancer patient’s blood.

Link to the conference.

Categories

#Internal #External

Latest news

Overwhelming interest from leading speakers in First Nordic conference on personalized medicine 11-04-2018
The conference in Nyborg looks mainly at the underlying mechanisms causing variability in clinical response and drug toxicity. We talked to organizer...
Cancer therapies: How we link drug sensitivity to molecular profiling to identify biomarkers 23-03-2018
Professor Krister Wennerberg talks on stratified cancer therapies and their predictive biomarkers at the Oncology Network meeting April 9th.
Biopeople i nyt samarbejde med magasinet Life Science 22-03-2018
I 2018 har Biopeople indgået et samarbejde med bladet Life Science – Dansk Biotek (in Danish only).
Call: USA East Coast Innovation Tour - Greater Boston & Greater New York - deadline March 30th 21-03-2018
The Innovation Tour is specifically focused on life science companies from Europe to explore research, commercialization and investment opportunities...
Internationalt uddannelsessamarbejde inden for regulering af medicin 20-03-2018
Den 27. februar 2018 arrangerede Biopeople og Copenhagen Centre for Regulatory Science en international workshop for mere end 25 unge forskere fra...

Related

Close
What are you looking for?
This site uses the functionality that older versions of Internet Explorer does not support. You should therefore switch or upgrade your browser.